05.03.19 | AI and Health: Just Be Patient

Media Centre

05.03.19 | AI and Health: Just Be Patient

5 March 2019

  • What is the current state of AI in health-tech, and what lies in the future?
  • What are the technical, ethical and commercial challenges that are evolving together with this new frontier?
  • How do digital technologies and the commercialisation of medical databases coincide with the rise of privacy laws?

There is really no limit to the potential of harnessing AI in healthcare and particularly in digital health.

It is hard to overstate the impact and implications AI and Machine Learning technologies have on our lives today. We constantly hear of new ways in which these technologies are being used to improve the effectiveness of health-related services and products – from early detection of medical conditions, personalised medication, and psychological evaluations, to improved adherence, genetic sequencing, smart decision support systems and more.

We are just at the beginning: investments in digital health are abundant and the market is expected to exceed billions of dollars within the next four years. With tech giants joining this digital health revolution, creating products and services, this ever-developing sphere will only continue to grow.

Join Herzog Fox & Neeman’s Technology and Regulation Department at our AI and Health Event, where you will hear from inspirational speakers, researches, investors and startups who will showcase emerging developments and predictions, business models, as well as explore the ethical and regulatory challenges presented by the implementation of AI in digital health.


Gathering & Registration
Opening Remarks
Ariel Yosefi, Partner, Co-Head of Technology & Regulation Department, Herzog Fox & Neeman
The State of AI in Healthcare
Dr. Nimrod Kozlovski, Partner, Co-Head of Technology & Regulation Department, Herzog Fox & Neeman
Regulating the MDIoT devices that feed the AI
Prof. Dov Greenbaum, Director, Zvi Meitar Institute for Legal Implications of Emerging Technologies; Professor of Law, IDC Herzliya
AI in Health: The Promise, the Hype and the Risk
Dr. Ronit Almog, Director, Epidemiology Unit and Biobank, Rambam Health Care Campus
INFIBOND | Empathetic Avatar & its impact on the future of health
Yoram Kraus , Co-Founder & CEO, Infibond
Maya Barlev, CPMO and organizational & occupational psychologist, Infibond
Coffee Break
Digital Health and Open Innovation | Local & Global Perspective
Assaf Barnea, CEO, Sanara Ventures
Harnessing AI in the Fight Against Cancer
Avi Veidman , CEO, Nucleai
New Opportunities in Personalized Medicine
Dr. Talia Cohen Solal, CEO, Genetika+

Search by +